Gessel has advised Wroclaw-based biopharmaceutical company Pure Biologics on receiving a PLN 12 million investment from ACRX Investments Limited.
ACRX is a European-based distribution and acquisition company.
According to Gessel, “the transaction was executed on the basis of an investment agreement and a loan agreement.”
Earlier in 2023, Gessel advised Pure Biologics on its public offering of shares (as reported by CEE Legal Matters on January 5, 2023).
The Gessel team included Partner Krzysztof Marczuk, Managing Associate Michal Wielinski and Magdalena Szeplik, and Associates Dawid Marciniak and Michal Dunikowski.
Gessel did not respond to our inquiry on the matter.
